The New York Times is reporting that there are a number of pharmaceutical companies in the US working to develop drugs to treat celiac disease.
According to the Times, such drugs aren’t expected to be available to the public until at least 2018, and most are not being designed to “cure” celiac — rather, to help mitigate symptoms for those who have been exposed to gluten through food.
At least one company is said to be working on an injection that would provoke an immune reaction; it would work the same way many allergy shots do. However, this approach is considered by experts to be “a long shot.”
One advocate for people with celiac suggests that “the introduction of drugs would help society and the medical community take the disease more seriously, leading more doctors to screen patients for the illness.”
The main challenge of such drug development is how to measure the effectiveness of celiac disease drugs in clinical trials.
You can read the full article here.